Kishan A.T. Naipal

Functional <i>Ex Vivo</i> Assay to Select Homologous Recombination–Deficient Breast Tumors for PARP Inhibitor Treatment

Kishan A.T. Naipal, Nicole S. Verkaik, Najim Ameziane et al. · Clinical Cancer Research · 2014 · 164 citations

Tumor slice culture system to assess drug response of primary breast cancer

Kishan A.T. Naipal, Nicole S. Verkaik, Humberto Sánchez et al. · BMC Cancer · 2016 · 154 citations · Full text

Functional <i>Ex Vivo</i> Assay Reveals Homologous Recombination Deficiency in Breast Cancer Beyond BRCA Gene Defects

Titia G. Meijer, Nicole S. Verkaik, Anieta M. Sieuwerts et al. · Clinical Cancer Research · 2018 · 65 citations · Full text

Targeted inhibition of metastatic melanoma through interference with Pin1-FOXM1 signaling

Flore Kruiswijk, Sebastian C. Hasenfuss, Renuka Sivapatham et al. · Oncogene · 2015 · 59 citations · Full text

DNA damage response and anti-apoptotic proteins predict radiosensitization efficacy of HDAC inhibitors SAHA and LBH589 in patient-derived glioblastoma cells

Lotte M.E. Berghauser Pont, Kishan A.T. Naipal, Jenneke J. Kloezeman et al. · Cancer Letters · 2014 · 44 citations

Neuro-oncology, Radiation Therapy, Glioma +11